View Older Stories View More Recent Stories

May 6, 2025 07:30AM Bioventus Reports First Quarter Financial Results
Apr 28, 2025 08:00AM Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
Mar 11, 2025 07:30AM Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
Feb 28, 2025 07:30AM Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
Jan 7, 2025 08:00AM Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Jan 2, 2025 08:00AM Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
Nov 5, 2024 07:30AM Bioventus Reports Third Quarter Financial Results
Oct 29, 2024 07:30AM Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
Oct 1, 2024 09:00AM Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
Aug 7, 2024 04:15PM Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
Aug 6, 2024 07:30AM Bioventus Reports Second Quarter Financial Results
Jul 30, 2024 07:30AM Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
May 7, 2024 07:00AM Bioventus Reports First Quarter Financial Results
Apr 29, 2024 07:30AM Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
Mar 12, 2024 07:30AM Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
Mar 4, 2024 08:00AM Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
Jan 18, 2024 04:16PM Bioventus (BVS) Enters into an Amendment to Enhance Financial and Operational Flexibility
Jan 18, 2024 04:15PM Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
Jan 12, 2024 04:15PM Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
Dec 19, 2023 04:30PM Bioventus (BVS) Appoints Robert Claypoole as CEO and President
Dec 19, 2023 04:30PM Bioventus Names Robert Claypoole as President and Chief Executive Officer
Dec 6, 2023 08:02AM Bioventus (BVS) Agrees to Nationwide Contract with Aetna Medicare Advantage Plans for DUROLANE for Knee Osteoarthritis
Dec 6, 2023 08:00AM Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
Nov 7, 2023 07:00AM Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
Oct 31, 2023 07:00AM Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
Sep 19, 2023 09:52PM Bioventus to Present at the Cantor Global Healthcare Conference
Sep 6, 2023 04:30PM Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
Aug 8, 2023 07:30AM Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
Aug 4, 2023 08:30AM Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
Aug 1, 2023 05:35PM Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
May 23, 2023 07:30AM Bioventus Completes Divestiture of its Wound Business
May 16, 2023 04:15PM Bioventus Reports First Quarter Financial Results
May 15, 2023 05:33PM Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
May 11, 2023 07:00AM Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
May 10, 2023 09:00AM Bioventus Announces Divestiture of its Wound Business
Apr 5, 2023 08:02AM Bioventus (BVS) Announces CEO Leadership Change
Apr 5, 2023 08:00AM Bioventus Announces CEO Leadership Change
Mar 31, 2023 07:30AM Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
Mar 31, 2023 07:05AM Bioventus (BVS) Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
Mar 31, 2023 07:00AM Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
Mar 29, 2023 08:55AM Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
Mar 16, 2023 08:30AM Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
Feb 28, 2023 07:32AM Bioventus (BVS) Enters Settlement Agreement
Feb 28, 2023 07:30AM Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition
Jan 4, 2023 07:00AM Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference
Nov 21, 2022 05:15PM Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
Nov 16, 2022 05:15PM Bioventus Files for Extension to File Form 10-Q for the Period Ended October 1, 2022
Nov 8, 2022 07:30AM Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
Oct 31, 2022 07:00AM Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
Oct 12, 2022 08:00AM Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago   
View More Recent Stories View Older Stories